Damora Therapeutics (DMRA) Depreciation and Depletion (2021 - 2026)
Damora Therapeutics posted quarterly Depreciation and Depletion of $5000.0 for Q1 2026, little changed year-on-year from $5000.0 in Q1 2025, and down 16.67% on a QoQ basis from $6000.0 in Q4 2025.
Damora Therapeutics (DMRA) has 6 years of Depreciation and Depletion data on file, last reported at $5000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion changed 0.0% year-over-year to $5000.0; the trailing twelve-month figure through Mar 2026 stood at $23000.0 (up 9.52% YoY), and the FY2025 full-year result was $22000.0, up 4.76% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $5000.0, down from $6000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $211000.0 in Q3 2023 and bottomed at $5000.0 in Q1 2024.
- The 5-year median for Depreciation and Depletion is $6000.0 (2022), against an average of $21176.5.
- The widest annual swing landed in 2023, when Depreciation and Depletion jumped 3416.67%; it then tumbled 97.16% in 2024.
- A 5-year view of Depreciation and Depletion shows it stood at $21000.0 in 2022, then grew by 9.52% to $23000.0 in 2023, then plunged by 78.26% to $5000.0 in 2024, then gained by 20.0% to $6000.0 in 2025, then retreated by 16.67% to $5000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $5000.0 (Q1 2026), $6000.0 (Q4 2025), and $6000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 211,000.00 |
| Sep 30, 2023 | 211,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Dec 31, 2022 | 21,000.00 |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |